Targeting One Type of Immune Cell With Another Slows Cancer Growth in Preclinical Studies
New York, NY (PRWEB) October 25, 2022 -- A new approach to cancer immunotherapy that uses one type of immune cell to kill another—rather than directly
Source: prweb.com